Skip to main content

Table 2 Univariate and multivariate analysis results in Training cohort(n = 116)

From: Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery

Variable Univariate analysis Multivariate analysis   
  P HR 95%CI P
Gender
Male vs Female
.545    
Age (years)
≤60 vs >60
.175    
Smoking history
Never vs Ever
.516    
Drinking history
No vs Yes
.128    
Family history of tumor
No vs Yes
.858    
Underlying diseases
No vs Yes
.176    
Tumor size
≤6 vs >6
.225    
pT stage .020 Reference   
T1 vs T2–3   7.518 1.355–41.718 .021
Masaoka stage
I vs II-III
.097    
WHO stage .015 Reference   .016
A-AB vs B1-B3   .379 .070–2.040
A-AB vs C   5.892 .660–52.582
Myasthenia gravis,
No vs Yes
.434    
tumor capsule status
Incomplete vs Complete
.000    .088
Invasion of great vessels
No vs Yes
.000    .117
ALB .001 Reference   
≤40.8 vs >40.8   .157 .035–.697 .015
GLB
≤28.8 vs >28.8
.446    
A/G
≤1.5 vs >1.5
.344    
NE
≤5.6 vs >5.6
.004    .261
LY
≤2.5 vs >2.5
.305    
NE/LY (NLR) .000 Reference   
≤3.0 vs >3.0   15.426 1.759–135.300 .014
PLT
≤237 vs >237
.075    
PLT/LY (PLR)
≤161.6 vs >161.6
.041    .082
PLT/NE*LY (SII)
≤764.3 vs >764.3
.010    .196
  1. NLR neutrophil-to-lymphocyte ratio, Hb hemoglobin, ALB albumin, BMI body mass index, NE neutrophil count, LY lymphocyte count, GLB globulin, SII systemic immune-inflammation Index, PLT platelet, PLR platelet-lymphocyte ratio, pT stage pathological T stage